MedTrace Logo

Radiation Therapy in Treating Patients With Metastases to the Lymph Nodes in the Neck From an Unknown Primary Tumor

NCT00047125 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2018-07-09

No results posted yet for this study

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Giving radiation therapy in different ways may kill more tumor cells. It is not yet known which regimen of radiation therapy is more effective in treating patients who have metastases to the lymph nodes in the neck.

PURPOSE: Randomized phase III trial to compare different radiation therapy regimens in treating patients who have metastases to the lymph nodes in the neck from an unknown primary tumor.

Conditions

  • Carcinoma of Unknown Primary

Interventions

RADIATION

radiation therapy

Sponsors & Collaborators

  • Radiation Therapy Oncology Group

    collaborator NETWORK

  • NCIC Clinical Trials Group

    collaborator NETWORK

  • Danish Head and Neck Cancer Group

    collaborator NETWORK

  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • Vincent G. Gregoire, MD, PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain

  • Sharon A. Spencer, MD · University of Alabama at Birmingham

  • Samy El-Sayed, MD, FFR, FRCR, FRCP · Ottawa Regional Cancer Centre

  • Esat M. Ozsahin, MD, PhD · Centre Hospitalier Universitaire Vaudois

  • Cai Grau, MD · Aarhus Universitetshospital - Aarhus Sygehus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-07-31
Primary Completion
2004-07-31

Countries

  • United States
  • Belgium
  • Canada
  • Denmark
  • Netherlands
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00047125 on ClinicalTrials.gov